MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--TYRX ®, Inc., the leader in the commercialization of implantable medical devices designed to help reduce surgical-site infections (SSIs) associated with ...

In patients undergoing Cardiovascular Implantable Electronic Device (CIED) replacement procedures compared to similar high-risk cohorts, use of TYRX, Inc.'s AIGISRx® Antibacterial Envelope reduced ...

TYRX, a company that commercializes implantable combination drug and device products for infection control, announced that the 1,000th patient has been enrolled in the Citadel & Centurion clinical ...

The STEM Center of Excellence at The Citadel hosted the 7th annual competition and more than 100 teams, comprised of more than 1,000 participants, took part on Saturday, Feb. 11. Elementary school ...